Stifel Canada Upgrades Vitalhub (TSE:VHI) to Strong-Buy

Key Points

• Stifel Canada has upgraded Vitalhub (TSE:VHI) to a "strong-buy" rating, indicating increased confidence in the company's stock.
• Several brokerages are bullish on Vitalhub, with target prices ranging from C$14.50 to C$16.00, reflecting a consensus rating of "Buy" among analysts.
• Insider transactions have been noted, with directors selling shares, which has resulted in a reduction of their ownership percentages in the company.

Vitalhub (TSE:VHI - Get Free Report) was upgraded by Stifel Canada to a "strong-buy" rating in a report released on Tuesday,Zacks.com reports.

Several other brokerages have also issued reports on VHI. Raymond James Financial upped their target price on shares of Vitalhub from C$14.50 to C$15.00 and gave the stock an "outperform" rating in a research report on Tuesday, August 12th. Scotiabank increased their price target on shares of Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research report on Friday, June 20th. National Bankshares set a C$16.00 price objective on shares of Vitalhub and gave the stock an "outperform" rating in a report on Thursday, August 21st. Royal Bank Of Canada set a C$15.00 price objective on shares of Vitalhub and gave the company a "moderate buy" rating in a research note on Thursday, September 18th. Finally, Stifel Nicolaus set a C$15.00 target price on shares of Vitalhub and gave the company a "buy" rating in a report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating and seven have given a Buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of C$14.86.

Vitalhub Stock Up 0.7%

Shares of VHI stock opened at C$10.70 on Tuesday. The firm has a market cap of C$672.28 million, a P/E ratio of 133.75, a PEG ratio of 1.18 and a beta of 0.62. Vitalhub has a 12-month low of C$8.50 and a 12-month high of C$14.64. The company has a 50 day moving average of C$11.89 and a 200-day moving average of C$11.34.

Insider Transactions at Vitalhub

In other news, Director Danny Matlow sold 150,000 shares of the company's stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the completion of the transaction, the director directly owned 520,001 shares of the company's stock, valued at approximately C$6,630,012.75. This represents a 22.39% decrease in their ownership of the stock. Also, Director Steve Garrington sold 20,000 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the sale, the director owned 60,000 shares of the company's stock, valued at approximately C$774,000. This represents a 25.00% decrease in their ownership of the stock. 18.57% of the stock is currently owned by insiders.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.